ChronoScale CHRN 深 沪
等待开盘 10-14 09:30:00 美东时间
16.31
-1.570
-8.78%
华盛通- 最 高17.80
- 今 开17.80
- 成交量 30.98万股
- 最 低 15.32
- 昨 收 17.88
- 总市值 23.75亿
- 52周最高 30.00
- 市盈率 静 --
- 换手率 0.21%
- 52周最低 3.50
- 委 比 -89.47%
- 总股本 1.46亿
- 历史最高 1073.25
- 量 比 2.81
- 振 幅 13.87%
- 历史最低 3.4635
- 每 手 1
- 风险率 6.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Applied Digital (APLD) 2027财年第一季度业绩电话会议：营收增长322%，AI产能建设
Applied Digital在2027财年第一季度业绩电话会议上详细披露了3.419亿美元的营收、6440万美元的调整后EBITDA，以及将超过600兆瓦容量投入运营的计划。
10-07 23:41
ChronoScale Director Resigns Following Ekso Bionics Divestiture
ChronoScale ( ($CHRN) ) has issued an announcement. ChronoScale Holdings Corpor...
10-07 05:51
ChronoScale expands AI infrastructure contracts, refines growth focus
ChronoScale ( ($CHRN) ) has shared an announcement. ChronoScale completed the s...
10-03 05:48
At a glance: Stocks gapping up premarket
Here's a quick look at the stocks that are seeing gap-up moves before the bell on Friday. Stock index futures rose before the bell as investors braced for the September nonfarm payrolls report, with e...
10-02 20:31
ChronoScale Signs Contract Extension And New Agreement With AI Infrastructure Customers; Agreements Provide For $1B Annualized Run-rate Revenue By Q3 2027
Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 billion by calendar Q3 2027 ChronoScale completes previously disclosed sale of Ekso Bionics business u...
10-02 05:42
ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
ChronoScale Holdings Corporation has expanded an existing AI infrastructure customer agreement and signed a new customer contract, increasing its contracted deployment pipeline and aiming for $1 billion in annualized revenue by Q3 2027. The company has also completed the sale of its Ekso Bionics business unit, allowing it to focus on its core AI infrastructure business.
10-01 21:40
美股大行评级 | 奈飞遭看淡至57美元！现价仍有两成下行空间；Xenon制药遭多家机构降目标价，最低看至46美元
今日重点评级关注：康托·菲茨杰拉德：维持Abeona Therapeutics"超配"评级，目标价从28美元升至30美元；HC Wainwright & Co.：维持Oculis Holding"买入"评级，目标价从26美元升至39美元
09-21 16:25
Northland Capital Markets Initiates Coverage On ChronoScale Holdings with Outperform Rating, Announces Price Target of $32
Northland Capital Markets analyst Nehal Chokshi initiates coverage on ChronoScale Holdings (NASDAQ:CHRN) with a Outperform rating and announces Price Target of $32.
09-19 01:19
ChronoScale amends term loan, extends debt maturity
ChronoScale ( ($CHRN) ) has issued an announcement. On September 12, 2026, Chro...
09-17 05:29
Nutanix Recognized as a Leader in the Gartner® Distributed Hybrid Infrastructure Magic Quadrant™
Nutanix has been recognized as a Leader in the 2026 Gartner Magic Quadrant for Distributed Hybrid Infrastructure, acknowledged for its ability to execute and completeness of vision. The company's Nutanix Cloud Platform (NCP) provides a unified platform for running AI workloads, applications, and data across on-premises, cloud, and edge environments. Over the past year, Nutanix has expanded NCP with new capabilities for agentic AI, advanced Kubern...
09-10 15:00
